Tag: Diabetic complications** * **SGLT2 inhibitor therapy:** Directly references Tofogliflozin’s drug class and its mechanism of action

In a significant advancement in the management of diabetic kidney disease (DKD), researchers have initiated the TRUTH-DKD trial, which aims ...